B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 0.46 HKD -1.08% Market Closed
Market Cap: 242.5m HKD
Have any thoughts about
Broncus Holding Corp?
Write Note

Broncus Holding Corp
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Broncus Holding Corp
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
B
Broncus Holding Corp
HKEX:2216
Retained Earnings
-$405.5m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Retained Earnings
ÂĄ1.1B
CAGR 3-Years
66%
CAGR 5-Years
54%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Retained Earnings
ÂĄ9.2B
CAGR 3-Years
17%
CAGR 5-Years
23%
CAGR 10-Years
24%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Retained Earnings
ÂĄ31B
CAGR 3-Years
26%
CAGR 5-Years
35%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Retained Earnings
ÂĄ2.7B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Retained Earnings
ÂĄ4.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Broncus Holding Corp
Glance View

Market Cap
242.5m HKD
Industry
Health Care

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Intrinsic Value
0.65 HKD
Undervaluation 29%
Intrinsic Value
Price
B

See Also

What is Broncus Holding Corp's Retained Earnings?
Retained Earnings
-405.5m USD

Based on the financial report for Dec 31, 2023, Broncus Holding Corp's Retained Earnings amounts to -405.5m USD.

What is Broncus Holding Corp's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
-50%

Over the last year, the Retained Earnings growth was -7%. The average annual Retained Earnings growth rates for Broncus Holding Corp have been -50% over the past three years .

Back to Top